Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01169064 · ClinicalTrials.gov registry record · NA

Topical Silver for Prevention of Wound Infection After Cesarean Delivery

A NA study, sponsored by Vanderbilt University.

Terminated
Registry status
NA
Development phase
475
Enrollment target

NCT01169064: Clinical Trial NA study, sponsored by Vanderbilt University.

NCT01169064 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 475 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01169064, a NA study, was terminated before completion, sponsored by Vanderbilt University.

TERMINATED
Registry status
NA
Development phase
475 participants
Enrollment target

Study Summary

A common concern in any surgical procedure is the occurrence of infection. Silver-containing treatments are popular and used in wound treatment; however, there is presently little evidence of the effectiveness of silver-containing treatment for the prevention of obstetrical wound infection. We plan to investigate the rate of infection in women experiencing cesarean sections at Vanderbilt University Medical Center (VUMC) by comparing the infection rate based on a randomized choice of silver-containing wound dressings to soft cloth adhesive wound dressings.

Primary Outcome

As measured by number of patients with postop infections at 6 wks

Interventions

  • DEVICE Silver-containing surgical dressing
  • DEVICE Cloth adhesive dressing

Trial Details

FieldValue
Enrollment Target 475 participants
Start Date 2010-07
Est. Completion 2012-07
Phase NA
Vanderbilt University

430 total trials

Why NCT01169064 stopped before completion

NCT01169064 is an interventional study that assigns participants to a tested intervention. The registered 475 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).

The record links to 0 conditions, and to 2 interventions - of which Silver-containing surgical dressing is the first listed.

NCT01169064 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01169064 about?

NCT01169064 is a clinical study titled "Topical Silver for Prevention of Wound Infection After Cesarean Delivery". A common concern in any surgical procedure is the occurrence of infection. Silver-containing treatments are popular and used in wound treatment; however, there is presently little evidence of the effectiveness of silver-containing treatment for the prevention of obstetrical wound infection. We plan ...

What is the current status of trial NCT01169064?

This trial is currently terminated. It is a NA study. The enrollment target is 475 participants. The study started on 2010-07. Estimated completion is 2012-07.

What interventions are being tested in trial NCT01169064?

The interventions under investigation include: Silver-containing surgical dressing (DEVICE), Cloth adhesive dressing (DEVICE).

Who is sponsoring clinical trial NCT01169064?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01169064's enrollment target sits among peer trials

475 220th of 2000 higher than 1,781 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01788839 · 475 participants

    Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

  • NCT05451303 · 475 participants

    Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

  • NCT06892379 · 475 participants · Phase 1

    A Study of HS-20110 in Participants With Advanced Solid Tumors

  • NCT06754046 · 476 participants · NA

    BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01169064, the US trial registry maintained by the National Library of Medicine. NCT01169064 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.